4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0001177648-18-000040
Options or other derivatives
- President and CEO acquired 68,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Luly Jay R. · President and CEO
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2018-11-16 | Grant or award : show line 1 in the form Stock Option (right to buy) | +68,000 | $81.20 | 2028-11-16 | 68,000 | 68,000 | D |
Loading xslF345X03/edgar.xml…